Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium
Martin F. Reiner(University of Zurich), Giovanni G. Camici(University of Zurich), Simon F. Stämpfli(University Hospital Zurich), Gianluigi Savarese(Karolinska Institutet), Volkmar Falk(ETH Zurich), Jürg H. Beer(University of Zurich), Jan Steffel(Zurich Heart House), Francesco Maisano(Vita-Salute San Raffaele University), Stephan Sylvest Keller(University of Zurich), Erik W. Holy(Segeberger Kliniken), Heidi Amstalden(University of Zurich), Martina Glanzmann(University of Zurich), Stefano Benussi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Alexander Breitenstein(University of Zurich), Thomas F. Lüscher(University of Zurich), Nicole R. Bonetti(University Hospital Zurich)
Cited by 12
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
|European Heart Journal|2014|4.4k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k